# HLA-mismatched Microtransplantation for High Risk Acute Myeloid Leukemia

> **NCT01484171** · PHASE3 · UNKNOWN · sponsor: **The Affiliated Hospital of the Chinese Academy of Military Medical Sciences** · enrollment: 50 (estimated)

## Conditions studied

- Acute Myeloid Leukemia

## Interventions

- **DRUG:** idarubicin
- **BIOLOGICAL:** microtransplantation

## Key facts

- **NCT ID:** NCT01484171
- **Lead sponsor:** The Affiliated Hospital of the Chinese Academy of Military Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-08
- **Primary completion:** 2017-08
- **Final completion:** 2017-12
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2016-07-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01484171

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01484171, "HLA-mismatched Microtransplantation for High Risk Acute Myeloid Leukemia". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01484171. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*